The North American Viral Hepatitis Elimination Summit, a collaboration of the American Association for the Study of the Liver (AASLD), Canadian Association for the Study of the Liver (CASL), and Mexican Association of Hepatology (AMH) will be delivered on Tuesday March 18th, 2025, at the Global Hepatitis Summit in Los Angeles.
March 18th, 2025
10AM to 5PM
Objectives:
- Bring high level attention to hepatitis elimination in North America
- Advance knowledge of strategies to reduce health disparities
- Explore novel programs that how to apply these more broadly across countries in North America
Introductions and Overview
Co-Chairs: Jordan Feld (CASL), Norah Terrault (AASLD), Sergio Muñoz (AMH) Moderators: Jordan Feld, Aldo Torre, Norah Terrault / John Ward
NAVHES Session #1 - Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives
Moderators: John Ward & Carla Coffin
Canada – Canada’s STBBI Action Plan 2024-2030
Session #1 - Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives
Mexico – Expansion of HCV management in primary care
Session #1 - Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives
United States - US HCV elimination in transition
Session #1 - Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives
Panel Discussion
Session #1 - Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives
NAVHES Session #2 - Diagnostics with the goal of increasing treatment
Moderators: Norah Terrault & Sergio Muñoz
HCV POCT and barriers to test & treat approach
Session #2 - Diagnostics with the goal of increasing treatment
HBV testing – what needs to ∆ in policies & practice (qHBsAg, HBV POCT)
Session #2 - Diagnostics with the goal of increasing treatment
HDV: reflex testing, status of anti-HDV & RNA testing in NA
Session #2 - Diagnostics with the goal of increasing treatment
Panel Discussion
Session #2 - Diagnostics with the goal of increasing treatment
NAVHES Session #3 - Vaccination – an important cornerstone in Prevention
Moderators: John Ward & Carla Coffin
Suggest Catch-up HepB Vaccination Strategies for all or at risk adults
Session #3 - Vaccination – an important cornerstone in Prevention
HCV Vaccine trials in NA status report
Session #3 - Vaccination – an important cornerstone in Prevention
Lunch Symposium
NAVHES Session #4 - Prevention Beyond Vaccination
Moderators: Jordan Feld & Graciela Castro
Next Steps in Elimination of MTCT of HBV and HCV in North America
Session #4 - Prevention Beyond Vaccination
Liver cancer in VH in North America – surveillance challenges and solutions
Session #4 - Prevention Beyond Vaccination
Panel Discussion
Session #4 - Prevention Beyond Vaccination
NAVHES Session #5- Health equity: Delivering VH care in persons using drugs
Moderators: Norah Terrault & Sergio Muñoz
Prevention of HCV among PWID in Mexico
Session #5- Health equity: Delivering VH care in persons using drugs
PWIDs – novel programs in U.S.
Session #5- Health equity: Delivering VH care in persons using drugs
Supervised injection sites and SSPs in Canada
Session #5- Health equity: Delivering VH care in persons using drugs
Panel Discussion
Session #5- Health equity: Delivering VH care in persons using drugs
Wrap-up and Next Steps - Blueprint/Roadmap strategy
Moderators: John Ward, Norah Terrault, Jordan Feld & Sergio Muñoz
